Press Releases :: Soliton, Inc. (SOLY)

Soliton's RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation

Mar 8, 2019

Soliton Receives FDA Approval for Small Business Designation

Mar 4, 2019

Soliton Discusses Rapid Acoustic Pulse Technology for Treatment of Cellulite

Feb 28, 2019

Soliton Receives Additional Patent for Breakthrough Acoustic Shockwave Technology

Feb 26, 2019

Soliton, Inc. Completes IPO and Begins Trading on Nasdaq Under Ticker Symbol “SOLY”

Feb 19, 2019

Soliton completes second generation device further enhancing aesthetic capabilities

Feb 7, 2019

Soliton Receives Additional Patent for New Acoustic Shockwave Tattoo Removal Technology

Jan 3, 2019

Soliton Receives Prestigious Award for Its Breakthrough Acoustic Shockwave Technology

Dec 18, 2018

First Name*
First
Email*
Cell (Optional: Used For Press Releases)

© 2019 Soliton Inc. All Rights Reserved, Soliton Inc.